We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Everus Stock Falls 15% in Three Months: Is a Rebound Ahead?
Read MoreHide Full Article
Key Takeaways
Everus stock sank 15.5% in three months, trailing its industry amid profit-taking and valuation concerns.
Everus' backlog reached a record $4.55B, up 53%, as data center demand and acquisitions drove growth.
Everus raised 2026 guidance, but softer margins, data center concentration and premium valuation pose risks.
Everus Construction Group, Inc. (ECG - Free Report) has seen its shares decline approximately 15.5% over the past three months, raising questions about a potential rebound. The stock has underperformed the Zacks Building Products - Miscellaneous industry’s 14.2% drop, the broader Zacks Construction sector’s 12.2% fall and the S&P 500 Index’s 3.3% rise over the same period. The pullback appears largely caused by profit-taking following the stock's earlier rally and concerns over its elevated valuation. Expectations for moderating margins and substantial exposure to data center construction have also heightened investor caution.
Despite the weakness, Everus' underlying fundamentals remain encouraging. Strong data center demand, record backlog, improving cash generation and strategic acquisitions support its long-term growth prospects. However, execution risks and valuation concerns could limit near-term upside. The question is whether ECG's recent correction presents an attractive entry point or warrants continued caution.
ECG’s Three-Month Price Performance
Image Source: Zacks Investment Research
Over the past three months, ECG has also delivered mixed performance relative to its industry peers. Gibraltar Industries, Inc. (ROCK - Free Report) , EMCOR Group, Inc. (EME - Free Report) and Argan, Inc. (AGX - Free Report) recorded declines of 18.3%, 0.6% and 33.2%, respectively. ECG outperformed Gibraltar and Argan but lagged EMCOR.
Despite the recent stock pullback, Everus continues to benefit from robust demand across data centers, semiconductor facilities, hospitality and utility infrastructure. Its Electrical and Mechanical (E&M) business remains a key growth driver, supported by hyperscaler investments, expanding high-tech construction activity and strong customer relationships.
Everus' record backlog reached $4.55 billion at the end of second-quarter 2026, up 53% year over year, driven by organic project wins and contributions from the SE&M Constructors acquisition. E&M backlog increased 62%, while management expects approximately 80% of total backlog to convert into revenues within 12 months. Continued investments in grid modernization and utility infrastructure should further support its Transmission and Distribution (T&D) business.
Reflecting strong demand and project execution, management raised its 2026 revenue guidance to $4.5-$4.7 billion from $4.3-$4.4 billion and EBITDA guidance to $410-$425 million from $345-$360 million.
Everus is strengthening its capabilities and geographic reach through acquisitions. The April 2026 acquisition of SE&M Constructors expanded its E&M operations and contributed to backlog growth.
The subsequent $295 million acquisition of Epsilon Industries, completed in September, further strengthened Everus' modular construction capabilities. Epsilon specializes in off-site manufacturing of complex mechanical and electrical systems, serving data centers, advanced manufacturing and healthcare facilities. These investments complement management's long-term targets of 5%-7% annual organic revenue growth and 7%-9% EBITDA growth.
Strong Cash Flow Enhances Financial Flexibility
Everus' strengthening cash generation supports its financial position and long-term growth prospects. Operating cash flow increased to $196.8 million in the first half of 2026 from $32.5 million a year earlier, driven by improved operating performance and favorable working capital timing. Free cash flow surged to $167 million from $6.5 million, providing greater flexibility to fund organic expansion, strategic acquisitions and future investments.
However, management expects cash flow conversion to normalize in the second half as working capital benefits moderate and growth-related investments increase. Sustaining strong cash generation will remain important for supporting Everus' expansion strategy and financial flexibility.
Margin Pressures and Execution Risks Warrant Caution
Despite strong operational momentum, Everus faces challenges that could limit near-term profitability. Management expects EBITDA margins of approximately 8.5% in the second half of 2026, below the 10.4% achieved in the second quarter. This anticipated moderation reflects a more normalized profitability outlook and highlights the importance of maintaining execution discipline.
The company's significant exposure to data center construction also creates concentration risks. Any slowdown in hyperscaler investments, changes in customer spending priorities or project delays could affect backlog conversion and revenue growth.
Rising labor costs, skilled workforce shortages, supply chain disruptions and fixed-price contract exposure present additional challenges. Moreover, the integration of acquired businesses and investments required to support expansion could pressure operating margins and cash flow. Management also acknowledged that favorable working capital timing contributed to the first-half cash flow improvement, which may not be sustainable at the same pace.
Earnings Estimate Trend of ECG
ECG's earnings estimates for 2026 and 2027 have been revised upward over the past 60 days to $5.25 and $5.97 per share, respectively. The Zacks Consensus Estimates imply year-over-year earnings growth of 32.9% in 2026 and 13.7% in 2027, reflecting a favorable earnings outlook.
Image Source: Zacks Investment Research
Meanwhile, Gibraltar’s earnings are expected to decline 2% in the current year, while EMCOR and Argan are projected to deliver year-over-year growth of 27.5% and 40.9%, respectively.
ECG Stock Trades at a Premium
ECG stock is currently trading at a premium compared with the industry peers, with a forward 12-month price-to-earnings (P/E) ratio of 19.54, as the trend lines suggest below.
ECG P/E Ratio (Forward 12 Months)
Image Source: Zacks Investment Research
Is a Rebound Ahead for Everus Stock?
ECG stock has declined 15.5% over the past three months, reflecting profit-taking following its earlier rally and concerns over elevated valuation and margin sustainability. Despite the weakness, the company's underlying fundamentals remain encouraging, supported by robust construction demand and improving financial performance.
Strong data center investments, semiconductor construction and utility infrastructure spending continue to drive growth. Everus' record $4.55 billion backlog provides solid revenue visibility, while strategic acquisitions, including SE&M Constructors and Epsilon Industries, strengthen its capabilities and geographic reach. Improving operating efficiencies and robust cash generation further support its long-term prospects.
However, significant exposure to data center construction creates concentration risks, while labor shortages, project delays and rising costs could pressure profitability. Management's expectations for moderating second-half EBITDA margins and normalizing cash flow conversion also warrant caution. Although Everus' growth prospects remain favorable, its premium valuation and near-term execution risks could limit recovery potential. With a Zacks Rank #3 (Hold), investors may consider retaining existing positions while awaiting a more attractive entry point.
View the Zacks #1 Rank List
Image: Bigstock
Everus Stock Falls 15% in Three Months: Is a Rebound Ahead?
Key Takeaways
Everus Construction Group, Inc. (ECG - Free Report) has seen its shares decline approximately 15.5% over the past three months, raising questions about a potential rebound. The stock has underperformed the Zacks Building Products - Miscellaneous industry’s 14.2% drop, the broader Zacks Construction sector’s 12.2% fall and the S&P 500 Index’s 3.3% rise over the same period. The pullback appears largely caused by profit-taking following the stock's earlier rally and concerns over its elevated valuation. Expectations for moderating margins and substantial exposure to data center construction have also heightened investor caution.
Despite the weakness, Everus' underlying fundamentals remain encouraging. Strong data center demand, record backlog, improving cash generation and strategic acquisitions support its long-term growth prospects. However, execution risks and valuation concerns could limit near-term upside. The question is whether ECG's recent correction presents an attractive entry point or warrants continued caution.
ECG’s Three-Month Price Performance
Image Source: Zacks Investment Research
Over the past three months, ECG has also delivered mixed performance relative to its industry peers. Gibraltar Industries, Inc. (ROCK - Free Report) , EMCOR Group, Inc. (EME - Free Report) and Argan, Inc. (AGX - Free Report) recorded declines of 18.3%, 0.6% and 33.2%, respectively. ECG outperformed Gibraltar and Argan but lagged EMCOR.
Everus' Growth Strategy Remains Intact Despite Stock Weakness
Despite the recent stock pullback, Everus continues to benefit from robust demand across data centers, semiconductor facilities, hospitality and utility infrastructure. Its Electrical and Mechanical (E&M) business remains a key growth driver, supported by hyperscaler investments, expanding high-tech construction activity and strong customer relationships.
Everus' record backlog reached $4.55 billion at the end of second-quarter 2026, up 53% year over year, driven by organic project wins and contributions from the SE&M Constructors acquisition. E&M backlog increased 62%, while management expects approximately 80% of total backlog to convert into revenues within 12 months. Continued investments in grid modernization and utility infrastructure should further support its Transmission and Distribution (T&D) business.
Reflecting strong demand and project execution, management raised its 2026 revenue guidance to $4.5-$4.7 billion from $4.3-$4.4 billion and EBITDA guidance to $410-$425 million from $345-$360 million.
Strategic Acquisitions Create Additional Opportunities
Everus is strengthening its capabilities and geographic reach through acquisitions. The April 2026 acquisition of SE&M Constructors expanded its E&M operations and contributed to backlog growth.
The subsequent $295 million acquisition of Epsilon Industries, completed in September, further strengthened Everus' modular construction capabilities. Epsilon specializes in off-site manufacturing of complex mechanical and electrical systems, serving data centers, advanced manufacturing and healthcare facilities. These investments complement management's long-term targets of 5%-7% annual organic revenue growth and 7%-9% EBITDA growth.
Strong Cash Flow Enhances Financial Flexibility
Everus' strengthening cash generation supports its financial position and long-term growth prospects. Operating cash flow increased to $196.8 million in the first half of 2026 from $32.5 million a year earlier, driven by improved operating performance and favorable working capital timing. Free cash flow surged to $167 million from $6.5 million, providing greater flexibility to fund organic expansion, strategic acquisitions and future investments.
However, management expects cash flow conversion to normalize in the second half as working capital benefits moderate and growth-related investments increase. Sustaining strong cash generation will remain important for supporting Everus' expansion strategy and financial flexibility.
Margin Pressures and Execution Risks Warrant Caution
Despite strong operational momentum, Everus faces challenges that could limit near-term profitability. Management expects EBITDA margins of approximately 8.5% in the second half of 2026, below the 10.4% achieved in the second quarter. This anticipated moderation reflects a more normalized profitability outlook and highlights the importance of maintaining execution discipline.
The company's significant exposure to data center construction also creates concentration risks. Any slowdown in hyperscaler investments, changes in customer spending priorities or project delays could affect backlog conversion and revenue growth.
Rising labor costs, skilled workforce shortages, supply chain disruptions and fixed-price contract exposure present additional challenges. Moreover, the integration of acquired businesses and investments required to support expansion could pressure operating margins and cash flow. Management also acknowledged that favorable working capital timing contributed to the first-half cash flow improvement, which may not be sustainable at the same pace.
Earnings Estimate Trend of ECG
ECG's earnings estimates for 2026 and 2027 have been revised upward over the past 60 days to $5.25 and $5.97 per share, respectively. The Zacks Consensus Estimates imply year-over-year earnings growth of 32.9% in 2026 and 13.7% in 2027, reflecting a favorable earnings outlook.
Image Source: Zacks Investment Research
Meanwhile, Gibraltar’s earnings are expected to decline 2% in the current year, while EMCOR and Argan are projected to deliver year-over-year growth of 27.5% and 40.9%, respectively.
ECG Stock Trades at a Premium
ECG stock is currently trading at a premium compared with the industry peers, with a forward 12-month price-to-earnings (P/E) ratio of 19.54, as the trend lines suggest below.
ECG P/E Ratio (Forward 12 Months)
Image Source: Zacks Investment Research
Is a Rebound Ahead for Everus Stock?
ECG stock has declined 15.5% over the past three months, reflecting profit-taking following its earlier rally and concerns over elevated valuation and margin sustainability. Despite the weakness, the company's underlying fundamentals remain encouraging, supported by robust construction demand and improving financial performance.
Strong data center investments, semiconductor construction and utility infrastructure spending continue to drive growth. Everus' record $4.55 billion backlog provides solid revenue visibility, while strategic acquisitions, including SE&M Constructors and Epsilon Industries, strengthen its capabilities and geographic reach. Improving operating efficiencies and robust cash generation further support its long-term prospects.
However, significant exposure to data center construction creates concentration risks, while labor shortages, project delays and rising costs could pressure profitability. Management's expectations for moderating second-half EBITDA margins and normalizing cash flow conversion also warrant caution. Although Everus' growth prospects remain favorable, its premium valuation and near-term execution risks could limit recovery potential. With a Zacks Rank #3 (Hold), investors may consider retaining existing positions while awaiting a more attractive entry point.
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.